Diphenyl urea‐benzylidene acetohydrazide hybrids as fibroblast growth factor receptor 1 inhibitors and anticancer agents

Documenti analoghi

• Exploring new quinazolin‐4(3H)‐one derivatives as CDK2 inhibitors: Design, synthesis, and anticancer evaluation
  di: Basant T. Ibrahim, et al.
  Pubblicazione: (2024)
• Design, synthesis, and biological evaluation of dinaciclib and CAN508 hybrids as CDK inhibitors
  di: Dana M. Odeh, et al.
  Pubblicazione: (2024)
• Synthesis, characterization, molecular modeling studies, and biological evaluation of metal piroxicam complexes (M = Ni(II), Pt(IV), Pd(II), Ag(I)) as antibacterial and anticancer agents
  di: Aya M. Soliman, et al.
  Pubblicazione: (2024)
• 2‐Thioxo‐3,4‐dihydropyrimidine and thiourea endowed with sulfonamide moieties as dual EGFRT790M and VEGFR‐2 inhibitors: Design, synthesis, docking, and anticancer evaluations
  di: Mohamed S. A. El‐Gaby, et al.
  Pubblicazione: (2024)
• Synthesis, anticancer activity and mechanism of action of Fe(III) complexes
  di: Xiaoqian Zhao, et al.
  Pubblicazione: (2024)